Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Toll-like receptor signaling pathway | R-HSA-168898 | map04620 | novobiocin | 2467 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | novobiocin | 2467 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | novobiocin | 2467 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | novobiocin | 2467 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | novobiocin | 2467 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | fasudil | 3547 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | fasudil | 3547 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | mefenamic acid | 4044 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | mefenamic acid | 4044 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | mefenamic acid | 4044 | drug-path |
| Type II diabetes mellitus | R-HSA-2127377 | map04930 | mefenamic acid | 4044 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | mefenamic acid | 4044 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | mefenamic acid | 4044 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | mefenamic acid | 4044 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | mefenamic acid | 4044 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | mefenamic acid | 4044 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | mefenamic acid | 4044 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | atracurium besilate | 47320 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | atracurium besilate | 47320 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | atracurium besilate | 47320 | drug-path |